Related references
Note: Only part of the references are listed.Germline cancer predisposition variants and pediatric glioma: a population-based study in California
Ivo S. Muskens et al.
NEURO-ONCOLOGY (2020)
Challenges to curing primary brain tumours
Kenneth Aldape et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib
Yudong Su et al.
TARGETED ONCOLOGY (2019)
Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer
Peng Song et al.
CANCER MEDICINE (2019)
Genetic and molecular epidemiology of adult diffuse glioma
Annette M. Molinaro et al.
NATURE REVIEWS NEUROLOGY (2019)
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer
Yuan-sheng Zang et al.
CANCER MEDICINE (2019)
The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients
Ajay Chatrath et al.
MOLECULAR CANCER RESEARCH (2019)
Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study
Jaume Capellades et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas
Kosuke Aoki et al.
NEURO-ONCOLOGY (2018)
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations
Christina Alidousty et al.
JOURNAL OF PATHOLOGY (2018)
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer
Jamie E. Chaft et al.
LUNG CANCER (2018)
Role and targeting of anaplastic lymphoma kinase in cancer
Carminia Maria Della Corte et al.
MOLECULAR CANCER (2018)
Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series
Daniel I. Jacobs et al.
NEURO-ONCOLOGY (2018)
Two siblings with familial neuroblastoma with distinct clinical phenotypes harboring an ALK germline mutation
Ko Kudo et al.
GENES CHROMOSOMES & CANCER (2018)
CASP9 germline mutation in a family with multiple brain tumors
Michael W. Ronellenfitsch et al.
BRAIN PATHOLOGY (2018)
Advances in the molecular genetics of gliomas - implications for classification and therapy
Guido Reifenberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Genetic variation in human drug-related genes
Charlotta Pauline Irmgard Scharfe et al.
GENOME MEDICINE (2017)
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells
Marina Conde et al.
BMC CANCER (2017)
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Hanwen Bai et al.
NATURE GENETICS (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma
Chih-Cheng Hsieh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Cytotoxic and targeted therapy for hereditary cancers
Aglaya G. Iyevleva et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2016)
The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)
Andrew Tutt et al.
CANCER RESEARCH (2015)
Genome-wide association study identifies multiple susceptibility loci for glioma
Ben Kinnersley et al.
NATURE COMMUNICATIONS (2015)
Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma
Matthew N. Bainbridge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
M. Labussiere et al.
BRITISH JOURNAL OF CANCER (2014)
ALK gene amplification is associated with poor prognosis in colorectal carcinoma
P. Bavi et al.
BRITISH JOURNAL OF CANCER (2013)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis
Hairui Sun et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Using Germline Genomics to Individualize Pediatric Cancer Treatments
Navin Pinto et al.
CLINICAL CANCER RESEARCH (2012)
Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma-Rationale for Comprehensive Mutation Profiling
Jamie E. Chaft et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Mechanisms of disease: Neural stem cells and the origin of gliomas
N Sanai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
